Showing results (301-310 of 454) with videos related to

Sort By:
Pageof 46
International Journal of Molecular Sciences|January 23, 2020
Curcumin Affects HSP60 Folding Activity and Levels in Neuroblastoma CellsCeleste Caruso Bavisotto, Antonella Marino Gammazza, Filippa Lo Cascio, et al.
Journal of Cellular Physiology|August 31, 2016
Mild Aerobic Exercise Training Hardly Affects the Diaphragm of mdx MiceGiuseppe Morici, Monica Frinchi, Alessandro Pitruzzella, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 30, 2024
Promoting readthrough of nonsense mutations in CF mouse model: Biodistribution and efficacy of NV848 in rescuing CFTR protein expressionIgnazio Fiduccia, Federica Corrao, Maria Grazia Zizzo, et al.
Neuro-Oncology Practice|August 7, 2019
Epilepsy in the end of life phase of brain tumor patients: a systematic reviewJohan A F Koekkoek, Linda Dirven, Jaap C Reijneveld, et al.
Cancer Treatment Reviews|August 20, 2022
Tailoring neoadjuvant treatment of HR-positive/HER2-negative breast cancers: Which role for gene expression assays?Giovanna Garufi, Luisa Carbognin, Concetta Arcanà, et al.
Journal of Cancer|April 12, 2014
Eribulin mesylate in pretreated breast cancer patients: a multicenter retrospective observational studyTeresa Gamucci, Andrea Michelotti, Laura Pizzuti, et al.
Clinical Breast Cancer|March 28, 2025
Activity and Efficacy of Neoadjuvant Chemotherapy in Luminal-HER2 Negative Early Breast Cancer According to HER2 Score (Low vs. Score 0): A Retrospective StudyGiovanna Garufi, Luca Mastrantoni, Noemi Maliziola, et al.
Frontiers in Oncology|September 26, 2022
Controversial topics in metastatic HR+/HER2- breast cancer: Guiding treatment by a modified Delphi approachAlessandra Fabi, Giuseppe Buono, Emilio Bria, et al.
Oncotargets and Therapy|May 23, 2019
Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?Marina Elena Cazzaniga, Laura Biganzoli, Laura Cortesi, et al.
EXCLI Journal|August 4, 2021
Neutrophil-to-lymphocyte ratio, Factor VIII and Antithrombin III: inflammatory-clotting biomarkers in gliomaTatiana Koudriavtseva, Veronica Villani, Svetlana Lorenzano, et al.
Pageof 46